History matters: Preventing severe allergic transfusion reactions

Area of Science:

• Hematology
• Immunology
• Clinical Medicine

Background:

• Previous research indicated pretransfusion medication ineffectiveness for preventing allergic transfusion reactions (ATRs).
• These prior studies did not specifically account for patients with a history of ATR.

Purpose of the Study:

• To evaluate the efficacy of pretransfusion antiallergy medications in preventing ATRs.
• Focus on patients with a documented history of severe ATR.

Main Methods:

• Retrospective, single-center study from March 2018 to January 2024.
• Analysis of patient demographics, clinical data, and transfusion reactions from EHR.
• Statistical analysis using SPSS and machine learning in Python.

Main Results:

• 53 patients with 2767 transfusion encounters were analyzed.
• Premedication (P=.021), regular antiallergy medication (P<.001), and washing/volume reduction (P=.032) were associated with reduced ATR incidence.
• Significant decrease in ATRs observed in the study cohort.

Conclusions:

• Patients with a history of severe ATR benefit from pretransfusion antiallergy medications.
• Tailored pretransfusion medication strategies are crucial for managing ATR risk.